K
ELLEY
D
IET
(M
ETABOLIC
T
YPES
)
Dr. William Donald Kelley, an orthodontist from Texas, developed an anticancer dietary plan that was very similar to the Gerson diet, but with less stringent use of raw
plant foods. Kelley developed 10 basic diets with numerous variations, depending on the type of cancer and on certain aspects of the patient's condition. These
dietary plans range from vegan to red-meat-based diets. Kelley also recommended regular fasting, colonic irrigation (high enemas), and coffee enemas. Kelley also
included pancreatic enzymes in the treatment of cancer patients. One of his students, Nicholas Gonzalez, MD, has subsequently included high levels of nutritional
supplementation with micronutrients,
amino acids, glandular substances, and digestive enzymes. These programs are individually designed with the goal of
modulating sympathetic/parasympathetic imbalances.
A
YURVEDIC
D
IET
Ayurveda, developed centuries ago in India, is the oldest medical system known, and its ancient texts span all the major branches of medicine. The Ayurvedic system
of food and herbal selection revolves around the three
doshas, the innate tendencies that are built into an individual's total make-up. The three
doshas–
vita,
pitta, and
kapha–manifest in different physical characteristics or metabolic body types. The
dosha refers to a unique property of the individual that enables one to adapt to one's
environment either favorably or unfavorably. Factors such as stress and climate can alter each
dosha; imbalances in the
doshas can result in specific diseases.
Various foods, herbs, and emotions can either stabilize or disturb the balance of a given
dosha type. The Ayurvedic system is primarily vegetarian, although meat may
be prescribed for certain
doshas (e.g., one with a predominance of vata) (see
Chapter 11
for a detailed description of this system).
N
ATURAL
H
YGIENE
D
IET
First formulated in the early 1800s by Sylvester Graham, this diet has been popularized by Harvey and Marilyn Diamond, authors of
Fit for Life. A central premise is
proper food combinations to maximize digestion. Adherents follow specific rules about digestion, food selection, and usage. For example, fruits and vegetables are
never eaten together, nor are protein- and starch-rich foods. Raw, unprocessed foods and freshly squeezed juices are emphasized, as are fresh vegetables,
organically grown whenever possible. Occasional use of meat is allowed. Periodic fasting is practiced to remove accumulated toxins
from the previous diet or
environmental sources.
C
OMMENTARY ON
D
IETS OF
V
ARIABLE
N
UTRIENT
C
OMPOSITION
Several of these systems contain similar components that are part of the shifting paradigm of nutrition. Supporting any regimen that is low in fat and high in fiber, with
minimal amounts of animal protein, is consistent with the preponderance of epidemiologic and laboratory data on good health. However, no one has performed the
types of studies needed to validate these theories, and in some areas there are grounds for concern. For example, long-term adherence to the high-meat, type O diet
(prescribed for more than 40% of the population) may raise the risk of heart disease and several cancers. The potential atherogenicity of this diet may be complicated
further by the program's recommendation that type O individuals should avoid supplements of vitamin E and fish oil, both of which may help prevent heart disease.
Similarly, one of the 10 diets in the Kelley program calls for raw meat as well as raw meat juices. The resulting high-protein load may cause excessive bone resorption
and insulin-like growth factor secretion; also, there is risk of contamination with bacteria, particularly for those people with compromised immune systems.
The primarily vegetarian leaning of the Ayurvedic diet is likely to translate into general health improvements. At this time, however, there are limited published reports
of the therapeutic effects of Ayurvedic dietary practices per se. In contrast, a number of studies have been published on the use of Ayurvedic herbal agents as dietary
supplements. Similarly, the Natural Hygiene Diet has never been taken seriously by the medical establishment because there is no published evidence that this diet
offers health benefits superior to any other low-fat vegetarian plan. The emphasis on proper digestion and food combination may be helpful to people who suffer from
intestinal discomfort after eating.
In principle, the lack of cooked, high-fiber foods in a raw-foods regimen might be expected to produce deficiencies in various nutrients, because cooking (in
moderation) helps release nutrients from many foods. Juicing and use of organically grown foods can reduce the risk of these deficiencies. There are many anecdotes
supporting the use of this approach. In the author's clinical experience, however, raw-foods diets generally tend to be short-lived: adherents
tend to increase their
intake of energy-rich foods (nuts and nut butters) over time to compensate for the semifasting state, and they eventually switch back to regular consumption of
high-calorie foods or cooked foods.
The potential health applications of these dietary approaches remain largely undetermined. Although there are some intriguing associations with blood types, lectins,
and diseases, the blood-type theory of dietary selection rests on a set of as yet unsubstantiated assumptions about evolution and physiology. Documentation is scant
for Ayurveda as well. This explains why such esoteric-sounding systems are usually shunned and chastised by medical professionals. However, we should remain
open to the possibility that these noninvasive systems may have value. Scientific, clinically valid evaluations are needed before judgment can be passed in either
direction.
MEDICAL APPLICATIONS OF NUTRITIONAL BIOTHERAPY
The extent of current knowledge on nutritional influences on disease etiology and progression is too vast for a single chapter. The aim of this section is to highlight
major areas of clinical relevance whereby nutritional biotherapy may play a role, based on the evidence from nutritional epidemiology, with primary emphasis on
clinical trials. The following is a discussion of the efficacy and use of nutritional intervention for four major diseases: cancer, hypertension, coronary heart disease,
and diabetes.
Nutritional Biotherapy for Cancer
We have used nutritional biotherapy on two key areas of treatment in cancer: toxicity mitigation and potentiation of standard treatment. With regard to toxicity
mitigation, intravenous supplementation with antioxidant nutrients can reduce the damage induced by peroxidation from chemotherapy or radiotherapy (
38
,
39
).
Moreover, antioxidants improved the tolerance to chemotherapy and radiation (
40
). Fat- and water-soluble antioxidants may help alleviate the oxidative stress that
accompanies many types of chemotherapy, as well as high-calorie diets, psychological stress, and the aging process (
4
). Importantly, the results of in vivo studies
indicate that antioxidants will not simultaneously protect the tumor or interfere with the results of conventional treatment (
42
,
43
,
44
,
45
,
46
,
47
,
48
,
49
,
50
,
51
and
52
).
In the area of potentiating treatment, we now know that additive or synergistic relationships between nutrients and anticancer drugs
may increase the therapeutic
index, enabling lower doses of the chemotherapy agents to be used without diminishing tumor kill. In most therapeutic situations, the chemotherapy agents act by a
direct cytotoxic effect, and the biomodulators simply amplify that effect. In some cases, the drugs may have immunomodulatory properties that synergize with
immune-enhancing agents (
53
). For example, several trials demonstrated that vitamin A acted synergistically with chemotherapy and radiotherapy against metastatic
cancers (
54
,
55
and
56
). When combined with the collagenase inhibitor minocycline (an anti-angiogenic agent), beta-carotene significantly enhanced the antitumor
activities of several chemotherapy agents both in vitro and in vivo (
57
). Vitamin C potentiates the anticancer activity of chemotherapy agents in vivo (
58
) and in vitro
(
59
), particularly when combined with vitamin K (
60
,
61
,
62
,
63
and
64
).
Evidence from both randomized and nonrandomized trials indicates that laboratory findings may carry over into the clinical realm. Survival and other clinical outcomes
for chemotherapy-treated metastatic breast cancer have been improved with adjuvant use of high-dose oral vitamin A (
65
,
66
,
67
,
68
,
69
and
70
), antioxidant
micronutrients and nutriceuticals (including coenzyme Q10) (
71
,
72
,
73
and
74
), L-arginine (
75
,
76
), and folinic acid (the reduced form of the B vitamin, folic acid) (
77
,
78
,
79
,
80
and
81
). Low-fat diets may further improve the prognosis of breast cancer patients (
82
,
83
,
84
,
85
,
86
,
87
,
88
and
89
), although randomized trials are
needed to test this theory. In lung cancer patients, a randomized trial of adjuvant nutrition using high-dose vitamin A led to a significant reduction in tumor recurrences
following surgery (
90
). Other retinoids may hold therapeutic promise for increasing response rates and survival in patients with advanced non-small-cell lung cancer
(
91
,
92
,
93
,
94
,
95
,
96
and
97
), although response rates have been relatively low. A preliminary trial of small-cell lung cancer cases found that supplemental
antioxidants resulted in significant improvements in expected survival (
98
). Significant prevention of bladder cancer recurrences has been demonstrated in
randomized, placebo-controlled trials using vitamin B
6
(
99
) and various retinoids (
100
,
101
,
102
and
103
) and, more recently, using multiple antioxidants at
pharmacological doses versus the RDA for these micronutrients (
104
).
By far the strongest evidence for the efficacy of adjuvant nutrition, however, has been with various forms of leukemia. For example, clinical trials have demonstrated
that all-trans retinoic acid (ATRA, or tretinoin, the acidic form of retinol) induced complete remission rates ranging from 86 to 100% and
prolonged survival in acute
promyelocytic leukemia patients (APL) (
105
,
106
,
107
,
108
,
109
,
110
and
111
). Patients with refractory or relapsed APL have also shown significant improvements in
clinical response rates after ATRA supplementation (
112
,
113
,
114
,
115
and
116
). Patients diagnosed with advanced malignant melanoma may benefit by following
low-protein, vegetable-rich diets (
117
,
118
) or by supplemental retinoids (
119
,
120
and
121
). Less well substantiated at this time is the efficacy of adjuvant nutrition for
the treatment of pancreatic and prostate cancer and other gastrointestinal cancers, although there are promising preliminary reports.
Nutritional Biotherapy for Hypertension
The standard dietary advice for hypertensive patients consists of salt restriction, weight reduction (for obese patients), and reducing alcohol consumption (
122
,
123
).
The first two of these have been shown to interact with each other in an additive fashion (
124
,
125
and
126
). Additionally, diets rich in fish, fruit, and vegetables have
been shown to reverse mild hypertension, to enhance the effects of antihypertensive drugs, and to diminish fatal and nonfatal heart attack and stroke rates (
127
).
Low-fat, plant-based diets are also likely to halt the progression of atherosclerotic and thrombotic disease. Other potentially useful antihypertensive strategies include
antioxidant supplementation, cessation of smoking, and adoption of a regular exercise program (
128
,
129
,
130
and
131
). Similar strategies should be implemented in
combination with appropriate medication for moderate to more severe forms of hypertension.
The effects of diet on blood pressure have been reviewed elsewhere (
132
,
133
,
134
,
135
,
136
and
137
). The most compelling data concerning an antihypertensive
effect of low-fat, high-fiber diets come from a clinical study of the DASH diet (Dietary Approaches to Stop Hypertension ) (
138
) and from studies of vegetarians (
139
,
140
,
141
,
142
,
143
,
144
,
145
,
146
and
147
). Additionally, clinical trials and epidemiologic studies have demonstrated antihypertensive effects through seven
strategies:
1. Sodium restriction (
148
,
149
,
150
,
151
,
152
and
153
).
2. Supplemental potassium (
154
,
155
,
156
,
157
and
158
).
3. Supplemental magnesium (
159
,
160
and
161
).
4. Supplemental calcium (
162
,
163
and
164
); however, this is for women only because of the risk for prostate cancer (
165
); in older women, calcium should be
combined with magnesium to lower the risk of thrombosis (
166
).
5. Supplemental fish oil (
167
,
168
) (with restricted salt intake).
6. Vegetable oil (
169
,
170
and
171
).
7. Garlic (
172
,
173
,
174
,
175
,
176
and
177
).
Nutritional Biotherapy for Coronary Artery Disease (CAD)
Interventional cardiology refers not only to standard treatment (bypass surgery and angioplasty), but also to complementary management of CAD patients.
Supplementation with soy protein (
178
,
179
and
180
), garlic extracts (
181
,
182
and
183
), coenzyme Q10 (
184
,
185
and
186
), magnesium (
187
), vitamin E (ideally with
selenium) (
188
,
189
and
190
), or vitamin C (
191
,
192
and
193
) have demonstrated a range of beneficial therapeutic effects in the management of CAD patients.
Additionally, omega-3 fatty acid supplements, either from fish oil or flaxseed oil, may be useful adjuncts to nutritional protocols for CAD (
194
,
195
,
196
,
197
and
198
).
In the majority of clinical trials, supplemental use of fish oils significantly decreases the rate of restenosis following coronary angioplasty (
199
,
200
,
201
,
202
,
203
,
204
,
205
,
206
and
207
).
To date, seven clinical trials have demonstrated
that a low-fat diet, usually in conjunction with cholesterol-lowering drugs, can alter coronary lesions and substantially
retard CAD progression (
208
,
209
,
210
,
211
,
212
,
213
,
214
,
215
,
216
,
217
and
218
). In the highly publicized Lifestyle Heart Trial, Ornish et al. randomized 41 men
and women to either usual care or a low-fat diet along with stress management (1 hour per day) and aerobic exercise (3 hours per day) (
3
). Subjects in the
intervention group showed a decrease in average percentage diameter stenosis from 40 to 37.8%, whereas an increase was seen in the control group, 42.7 to 46.1%
(p = 0.001) (
3
). After 4 years, the intervention showed an even greater improvement in stenosis and significant improvement in calculated coronary flow reserve; in
contrast, patients in the control group had a further worsening of CAD progression (
219
,
220
). More recent follow-up has demonstrated continued benefits, including
CAD regression, with long-term compliance on this program (
3
), although some have questioned the angiographic criteria used in this study (
22
).
A larger randomized study (n = 113) in Germany found overall delayed lesion progression in a diet-and-exercise intervention group (n = 56) versus controls (n = 57)
(
222
). CAD progression was significantly retarded in the intervention group (23% versus 48%, p < 0.05), and regression was more pronounced in the intervention
group as well (32% versus 17%, p <1 0.05) (
223
). Taken together, these trials suggest that optimal clinical outcomes for CAD treatment may be accomplished through
the combined, individually tailored use of cholesterol-lowering drugs, bypass surgery, nutritional interventions, and lifestyle changes, such as exercise and stress
management.
1>
Dostları ilə paylaş: